Outcomes | CQ 25 mg/kg | CQ 40 mg/kg | OR1 (95%CI) |
---|---|---|---|
Total enrolled | 83 | 80 | Â |
Total lost, excluded, or withdrawn | 0 | 0 | Â |
Mean days to fever clearance2 (95% CI) | 2.6 (1.9, 3.3) | 2.6 (1.9, 3.3) | Â |
Mean days to parasite clearance (95% CI) | 2.9 (2.6, 3.1) | 3.1 (2.8, 3.3) | Â |
Treatment outcomes: n = 163 (%) | Â | Â | Â |
Adequate clinical and parasitological response | 13 (16) | 40 (50) | 1 |
Early treatment failure | 6 (7) | 6 (7) | 0.28 (0.07, 1.09) |
Late treatment failure*** | 64 (77) | 34 (43) | 0.16 (0.07, 0.35) |
Parasitological outcomes: n = 163 (%) | Â | Â | Â |
S | 13 (16) | 39 (49) | Â |
RI | 60 (72) | 40 (50) | Â |
RII | 10 (12) | 1 (1) | Â |
First-line treatment success: n = 52 (%) | Â | Â | Â |
Complete parasitological cure without recrudescence*** | 13 (16) | 39 (49) | 0.17 (0.08, 0.38) |
First-line treatment failures: n = 111 (%) | Â | Â | Â |
Age group | Â | Â | Â |
   0-5 | 17 (89) | 11 (61) | 0.18 (0.03, 1.05) |
   6-14** | 38 (86) | 24 (55) | 0.17 (0.06, 0.50) |
   15+* | 15 (75) | 6 (33) | 0.17 (0.04, 0.70) |
Gender | Â | Â | Â |
   Male** | 35 (81) | 15 (47) | 0.17 (0.06, 0.51) |
   Female** | 35 (88) | 26 (54) | 0.19 (0.07, 0.56) |
Camp | Â | Â | Â |
   Adizai | 17 (81) | 11 (52) | 0.26 (0.06, 1.12) |
   Baghicha** | 37 (84) | 24 (51) | 0.16 (0.06, 0.46) |
   Kagan | 16 (89) | 6 (50) | 0.23 (0.03, 1.63) |